Inventor profile of:

Matthew Michael Hamilton

City:

Hackettstown, New Jersey

Country:

United States

Published Applications:

25

Last publication date:

2018-04-12

Top Assignees for applications by Matthew Michael Hamilton

The entities that hold a legal rights for patent applications filed by inventor Hamilton Matthew Michael:

Recent patent applications by Hamilton Matthew Michael

Matthew Michael Hamilton from Hackettstown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-04-12
US20180099005A1
Human necessities

Chitosan covalently linked with small molecule integrin antagonist for targeted delivery

#2 | 2015-10-29
US20150306130A1
Human necessities

CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERY

#3 | 2015-09-17
US20150259295A1
Chemistry; metallurgy

SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS

#4 | 2015-07-16
US20150197726A1
Chemistry; metallurgy

Compounds for improved stem cell differentiation into hepatocytes

#5 | 2015-06-11
US20150158840A1
Chemistry; metallurgy

Compounds for improved stem cell differentiation into hepatocytes

#6 | 2015-05-14
US20150133512A1
Chemistry; metallurgy

N-ARYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTS

#7 | 2015-05-14
US20150133511A1
Chemistry; metallurgy

N-alkyltriazole compounds as LPAR antagonists

#8 | 2015-03-05
US20150065534A1
Chemistry; metallurgy

Integrin antagonist conjugates for targeted delivery to cells expressing LFA-1

#9 | 2015-02-05
US20150038523A1
Chemistry; metallurgy

Integrin antagonist conjugates for targeted delivery to cells expressing alpha-V-beta-3

#10 | 2015-01-29
US20150031715A1
Chemistry; metallurgy

Integrin antagonist conjugates for targeted delivery to cells expressing VLA-4

#11 | 2013-08-01
US20130197205A1
Human necessities

CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERY

#12 | 2013-08-01
US20130197059A1
Chemistry; metallurgy

INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1

#13 | 2013-03-07
US20130059834A1
Chemistry; metallurgy

Pyrrolopyrazine kinase inhibitors

#14 | 2011-06-02
US20110130438A1
Chemistry; metallurgy

Aniline analogs as glycogen synthase activators

#15 | 2011-05-12
US20110112161A1
Chemistry; metallurgy

Indole and indazole analogs as glycogen synthase activators

#16 | 2011-05-12
US20110112158A1
Chemistry; metallurgy

BENZISOXAZOLE ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS

#17 | 2010-07-29
US20100190979A1
Chemistry; metallurgy

DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS

#18 | 2010-07-01
US20100168419A1
Chemistry; metallurgy

Diacylglycerol Acyltransferase Inhibitors

#19 | 2009-07-02
US20090170864A1
Chemistry; metallurgy

Diacylglycerol acyltransferase inhibitors

#20 | 2009-04-23
US20090105273A1
Chemistry; metallurgy

Diacylglycerol acyltransferase inhibitors

#21 | 2009-04-16
US20090099201A1
Chemistry; metallurgy

Diacylglycerol Acyltransferase Inhibitors

#22 | 2009-04-09
US20090093497A1
Chemistry; metallurgy

Diacylglycerol acyltransferase inhibitors

#23 | 2009-03-19
US20090076275A1
Chemistry; metallurgy

DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS

#24 | 2007-05-31
US20070123504A1
Chemistry; metallurgy

Diacylglycerol acyltransferase inhibitors

#25 | 2007-03-01
US20070049632A1
Chemistry; metallurgy

Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase

InventorID:

128939 ⎘